{
    "2021-12-15": [
        [
            {
                "time": "2023-03-15",
                "original_text": "FDA Approves AbbVie's JAK Inhibitor Application For Active Psoriatic Arthritis",
                "features": {
                    "keywords": [
                        "FDA",
                        "Approves",
                        "AbbVie",
                        "JAK",
                        "Inhibitor",
                        "Psoriatic",
                        "Arthritis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "AbbVie (ABBV) Rinvoq Gets FDA Nod for Active Psoriatic Arthritis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rinvoq",
                        "FDA",
                        "Psoriatic",
                        "Arthritis"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Lilly (LLY) Phase III Study in Ulcerative Colitis Meets Goal",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Phase",
                        "III",
                        "Study",
                        "Ulcerative",
                        "Colitis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Pfizer (PFE) COVID Pill Maintains Strong Efficacy, Stock Up",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "COVID",
                        "Pill",
                        "Efficacy",
                        "Stock"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Idera Shares Fall After Early Tilsotolimod Data, Seeks Collaborating Partners For TLR9 Agonist",
                "features": {
                    "keywords": [
                        "Idera",
                        "Shares",
                        "Fall",
                        "Tilsotolimod",
                        "Data",
                        "TLR9",
                        "Agonist"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "5 Top Stock Gainers for Wednesday Before Fed's Key Policy Update",
                "features": {
                    "keywords": [
                        "Top",
                        "Stock",
                        "Gainers",
                        "Fed",
                        "Policy",
                        "Update"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "VIP Growth Opportunities Portfolio Buys Uber Technologies Inc, Lightspeed Commerce Inc, Chewy ...",
                "features": {
                    "keywords": [
                        "VIP",
                        "Growth",
                        "Opportunities",
                        "Portfolio",
                        "Buys",
                        "Uber",
                        "Lightspeed",
                        "Commerce",
                        "Chewy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "retail",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "VIP Growth and Income Portfolio Buys Universal Music Group NV, Vertiv Holdings Co, Tourmaline ...",
                "features": {
                    "keywords": [
                        "VIP",
                        "Growth",
                        "Income",
                        "Portfolio",
                        "Buys",
                        "Universal",
                        "Music",
                        "Group",
                        "Vertiv",
                        "Holdings",
                        "Tourmaline"
                    ],
                    "sentiment_score": 0.55,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "entertainment",
                        "industrial",
                        "energy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "VanEck Pharmaceutical ETF Buys Sanofi SA, AstraZeneca PLC, AbbVie Inc",
                "features": {
                    "keywords": [
                        "VanEck",
                        "Pharmaceutical",
                        "ETF",
                        "Buys",
                        "Sanofi",
                        "AstraZeneca",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}